XCUR earnings: real EPS beat/miss history, analyst consensus Buy, P/E -1.14. Updated 2026-07-23.
Exicure (XCUR) Research Hub
Exicure (XCUR) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 1.4 USD (-2.10%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.14, market cap 0.01B. This hub links to the full technical, earnings and options research available for XCUR.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 1.4 USD (-2.10%) |
| 52-week range | 1.05 USD – 3.2 USD |
| Trend regime | Range |
| 14-day RSI | 52.4 (Neutral) |
| Trailing P/E | -1.14 |
| Market cap | 0.01B |
| Dividend yield | 0.00% |
Available research for XCUR
Covered Call on XCUR: how it works, illustrative setup around the real 1.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on XCUR: how it works, illustrative setup around the real 1.4 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on XCUR: how it works, illustrative setup around the real 1.4 USD price, max profit/loss, breakeven and when to use it. Educational.
XCUR technical analysis: range, last 1.4 USD, RSI 52.4, 52w range 1.05 USD–3.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is XCUR in?
Exicure (XCUR) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is XCUR in an uptrend or downtrend?
As of 2026-09-11, XCUR is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is XCUR's trailing P/E ratio?
XCUR's trailing P/E is -1.14, with a market cap of 0.01B. See the earnings research page for full valuation detail.